These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome. Panhotra BR; Saxena AK; Al-Ghamdi AM Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657 [TBL] [Abstract][Full Text] [Related]
4. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study. Behar PR; Teixeira PJ; Fachel JM; Kalil AC J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center. Filozov A; Visintainer P; Carbonaro C; Aguero-Rosenfeld M; Wormser GP; Montecalvo MA Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935 [TBL] [Abstract][Full Text] [Related]
6. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. Lee CH; Su LH; Tang YF; Liu JW J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415 [TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia. Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Paterson DL; Mulazimoglu L; Casellas JM; Ko WC; Goossens H; Von Gottberg A; Mohapatra S; Trenholme GM; Klugman KP; McCormack JG; Yu VL Clin Infect Dis; 2000 Mar; 30(3):473-8. PubMed ID: 10722430 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population. Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004 [TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study. Demir S; Soysal A; Bakir M; Kaufmann ME; Yagci A J Paediatr Child Health; 2008 Oct; 44(10):548-53. PubMed ID: 18557808 [TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828 [TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513 [TBL] [Abstract][Full Text] [Related]
14. An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization. Gundes S; Arisoy AE; Kolayli F; Karaali E; Turker G; Sanic A; Arisoy ES; Vahaboglu H New Microbiol; 2005 Jul; 28(3):231-6. PubMed ID: 16240695 [TBL] [Abstract][Full Text] [Related]
15. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822 [TBL] [Abstract][Full Text] [Related]
16. Eradication of an extensive outbreak in a neonatal unit caused by two sequential Klebsiella pneumoniae clones harbouring related plasmids encoding an extended-spectrum beta-lactamase. Velasco C; Rodríguez-Baño J; García L; Díaz P; Lupión C; Durán L; Pascual A J Hosp Infect; 2009 Oct; 73(2):157-63. PubMed ID: 19716201 [TBL] [Abstract][Full Text] [Related]
17. Prompt control of an outbreak caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Cantey JB; Sreeramoju P; Jaleel M; Treviño S; Gander R; Hynan LS; Hill J; Brown C; Chung W; Siegel JD; Sánchez PJ J Pediatr; 2013 Sep; 163(3):672-9.e1-3. PubMed ID: 23582136 [TBL] [Abstract][Full Text] [Related]
19. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919 [TBL] [Abstract][Full Text] [Related]
20. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]